Open AccessBangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19
Author(s) -
Faruque Pathan,
Shahjada Selim,
. Fariduddin,
Hafizur Rahman,
SM Ashrafuzzaman,
Faria Afsana,
Nazmul Kabir Qureshi,
Tofazzal Hossain,
Mohammad Saifuddin,
A B Kamrul-Hasan,
Ahmed Salam Mir
Publication year - 2021
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s293688
Subject(s) - medicine , diabetes mellitus , endocrine system , diabetic ketoacidosis , hypoglycemia , guideline , intensive care medicine , disease , covid-19 , pandemic , comorbidity , endocrine disease , diabetes management , pediatrics , type 2 diabetes , endocrinology , hormone , infectious disease (medical specialty) , pathology
The year 2020 witnessed a largely unprecedented pandemic of coronavirus disease (COVID-19), caused by SARS COV-2. Many people with COVID-19 have comorbidities, including diabetes, hypertension and cardiovascular diseases, which are significantly associated with worse outcomes. Moreover, COVID-19 itself is allied with deteriorating hyperglycemia. Therefore, Bangladesh Endocrine Society has formulated some practical recommendations for management of diabetes and other endocrine diseases in patients with COVID-19 for use in both primary and specialist care settings.